Loading...

Pacific Blue™ anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_Blue_091207
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Pacific Blue™ (filled histogram) or rat IgG2b, κ Pacific Blue™ isotype control (open histogram) (gated on total cells).
  • M1slash70_Blue_091207
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Pacific Blue™ (filled histogram) or rat IgG2b, κ Pacific Blue™ isotype control (open histogram) (gated on total cells).
Compare all formats See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
101223 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101224 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  2. Zaman R, et al. 2021. Immunity. :. PubMed
  3. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  4. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  5. Jauch-Speer SL, et al. 2022. Elife. 11: . PubMed
  6. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  7. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  8. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  9. Cai S, et al. 2023. J Clin Invest. 133: . PubMed
  10. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  11. Kimura Y, et al. 2023. Front Immunol. 14:1070196. PubMed
  12. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  13. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  14. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  15. Liu PS, et al. 2023. Nat Immunol. 24:452. PubMed
  16. Golshadi M, et al. 2023. NPJ Regen Med. 8:12. PubMed
  17. Touré H, et al. 2023. PLoS Pathog. 19:e1011257. PubMed
  18. Herrejon Chavez F, et al. 2023. Nat Commun. 14:2290. PubMed
  19. Solier S, et al. 2023. Nature. 617:386. PubMed
  20. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  21. Wang X, et al. 2023. Stem Cell Rev Rep. . PubMed
  22. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  23. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  24. Arora H, et al. 2019. Immunity. 50:418. PubMed
  25. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  26. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  27. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  28. Sharma-Chawla N, et al. 2016. Infect Immun . . PubMed
  29. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  30. Sharma A, et al. 2014. J Infect Dis. . PubMed
  31. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  32. Schneider C, et al. 2018. Cell. 174:271. PubMed
  33. Shen S, et al. 2018. Pain Med. 19:686. PubMed
  34. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  35. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  36. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  37. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  38. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  39. Zhu H, et al. 2018. Elife. 7:. PubMed
  40. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  41. Silver AC, et al. 2018. Heliyon. 4:e00579. PubMed
  42. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  43. Janelsins B, et al. 2013. Blood. 121:2923. PubMed
  44. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  45. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  46. Uhl J, et al. 2019. J Cell Commun Signal. 13:209. PubMed
  47. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  48. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  49. Huang A, et al. 2014. Exp Cell Res. 15:326. PubMed
  50. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  51. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  52. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  53. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  54. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  55. Zhao X, et al. 2022. Cell Biosci. 12:3. PubMed
  56. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  57. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  58. Sitnik S, et al. 2020. Mol Ther Oncolytics. 17:190. PubMed
  59. Ummarino S, et al. 2021. Cells. 10:. PubMed
  60. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  61. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  62. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  63. Endo J, et al. 2014. J Exp Med. 211:1673. PubMed
  64. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  65. Fang EF, et al. 2019. Nat Neurosci. 22:401. PubMed
  66. Taherzadeh Z, et al. 2010. Am J Physiol Heart Circ Physiol. 298:H1273. PubMed
  67. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  68. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  69. Saravia J, et al. 2015. PLoS Pathog. 11: e1005217. PubMed
  70. Raines A, et al. 2013. Development. 140:2942. PubMed
  71. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
  72. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  73. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  74. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  75. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  76. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  77. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  78. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  79. Krishnamoorthy N, et al. 2015. J Immunol. 194:863. PubMed
  80. Krishnamurthy B, et al. 2015. Diabetes. 64: 3229-3238. PubMed
  81. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  82. Li N, et al. 2021. eLife. 10:00. PubMed
  83. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  84. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  85. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  86. Belgiovine C, et al. 2021. Eur J Immunol. 51:2677. PubMed
  87. Ren K, et al. 2022. Brain Behav. 12:e2456. PubMed
  88. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  89. Wu Y, et al. 2021. PLoS Negl Trop Dis. 15:e0010050. PubMed
  90. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  91. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  92. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  93. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  94. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  95. Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed
  96. Cheng Y, et al. 2019. Cell Rep. 28:1703. PubMed
  97. Park HB, et al. 2020. Nat Microbiol. 1319:5. PubMed
  98. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  99. Jonas B, et al. 2016. PLoS One. 11: 0159189. PubMed
  100. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  101. Sun P, et al. 2022. Nat Commun. 13:6562. PubMed
  102. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  103. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  104. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  105. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  106. Kar S, Colino J, Snapper C 2016. J Immunol. 196: 4204 - 4213. PubMed
  107. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  108. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  109. Souza SP, et al. 2021. PLoS Pathog. 17:e1010081. PubMed
  110. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  111. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  112. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  113. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  114. Tomlinson JE, et al. 2020. J Neurosci Methods. 331:108483. PubMed
  115. Barman S, et al. 2016. Int Immunol. 28: 533 - 545. PubMed
  116. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  117. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  118. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  119. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  120. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
  121. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  122. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  123. O'Leary CE, et al. 2021. Curr Protoc. 1:e77. PubMed
  124. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  125. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  126. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  127. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  128. Hill RZ, et al. 2018. Elife. 7:e33285. PubMed
  129. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  130. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  131. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  132. Tang S, et al. 2022. Virol J. 19:32. PubMed
  133. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  134. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  135. Hong S et al. 2018. Immunity. 49(4):695-708 . PubMed
  136. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  137. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  138. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  139. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  140. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  141. Kratochvill F, et al. 2015. Cancer Res. 75: 3054-3064. PubMed
  142. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  143. Smith LK, et al. 2021. Elife. 10:. PubMed
  144. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  145. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  146. Tomlinson JE, et al. 2018. J Neuroinflammation. 0.753472222. PubMed
  147. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  148. Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed
  149. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  150. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  151. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  152. Strait AA, et al. 2021. Commun Biol. 4:1005. PubMed
  153. Young JS, et al. 2018. Front Immunol. 9:1385. PubMed
  154. Park SM et al. 2018. Cell stem cell. 24(1):153-165 . PubMed
  155. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  156. Smith K, et al. 2012. Infect Immun . 80:3481. PubMed
  157. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  158. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  159. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  160. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  161. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  162. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  163. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
RRID
AB_755985 (BioLegend Cat. No. 101223)
AB_755985 (BioLegend Cat. No. 101224)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11b
Specificity Alt (DOES NOT SHOW ON TDS):
CD11b
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account